Im sure this will trend higher with the macro strongly in our favor and the near term catalysts. Restart program concept study, followed by financing, fid etc. Valuation is at rock bottom now and that is about to change.
- Forums
- ASX - By Stock
- CYM
- Ann: Investor Presentation
Ann: Investor Presentation, page-21
Featured News
Add CYM (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.8¢ |
Change
-0.003(14.3%) |
Mkt cap ! $27.46M |
Open | High | Low | Value | Volume |
2.0¢ | 2.0¢ | 1.8¢ | $30.30K | 1.571M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 2472215 | 1.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 154641 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 2472215 | 0.018 |
2 | 375000 | 0.017 |
2 | 357191 | 0.016 |
4 | 640000 | 0.015 |
2 | 200000 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 154641 | 2 |
0.021 | 350000 | 1 |
0.022 | 409218 | 2 |
0.023 | 290267 | 1 |
0.024 | 800000 | 2 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
CYM (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online